Headlands Technologies’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$379K Buy
72,378
+12,065
+20% +$41K 0.04% 483
2026
Q1
$106K Buy
60,313
+14,434
+31% +$31.3K 0.01% 660
2025
Q4
$108K Buy
45,879
+12,768
+39% +$34.9K 0.01% 626
2025
Q3
$101K Sell
33,111
-71,468
-68% -$204K 0.01% 573
2025
Q2
$292K Buy
104,579
+103,854
+14,325% +$341K 0.03% 402
2025
Q1
$2.6K Buy
+725
New +$2.91K ﹤0.01% 1032
2024
Q3
Sell
-162,057
Closed -$199K 1235
2024
Q2
$199K Buy
+162,057
New +$145K 0.02% 476

Other funds holding CLOV

Headlands Technologies's CLOV Position: Q2 2026 in Review

Headlands Technologies increased its Clover Health Investments (CLOV) stake by 20% in Q2 2026, buying an estimated $41K and bringing the position to 72,378 shares worth $379K. The position accounts for 0.04% of the portfolio, ranked #483.

Headlands Technologies first reported a position in CLOV in Q2 2024 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Headlands Technologies held 72,378 shares of Clover Health Investments worth $379K as of Q2 2026.
  • Headlands Technologies bought 12,065 Clover Health Investments shares in Q2 2026, an estimated $41K.
  • Clover Health Investments made up 0.04% of Headlands Technologies's portfolio in Q2 2026, its #483 holding.
  • Headlands Technologies first reported a position in Clover Health Investments in Q2 2024 and has held it in 7 quarters since.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.